|
pct_CD4_8 splenic CD4 T cells (percentage of total viable cells)
, at age age 8wks
23101
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_CD4_16 splenic CD4 T cells (percentage of total viable cells)
, at age age 16wks
23102
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
pct_CD8_8 splenic CD8 T cells (percentage of total viable cells)
, at age age 8wks
23103
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_CD8_16 splenic CD8 T cells (percentage of total viable cells)
, at age age 16wks
23104
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
pct_NKT_8 splenic NK T cells (percentage of total viable cells)
, at age age 8wks
23105
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_NKT_16 splenic NK T cells (percentage of total viable cells)
, at age age 16wks
23106
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
pct_NK_8 splenic NK cells (percentage of total viable cells)
, at age age 8wks
23107
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_NK_16 splenic NK cells (percentage of total viable cells)
, at age age 16wks
23108
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
pct_B_8 splenic B cells (percentage of total viable cells)
, at age age 8wks
23109
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_B_16 splenic B cells (percentage of total viable cells)
, at age age 16wks
23110
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
pct_Granu8 splenic granulocytes (percentage of total viable cells)
, at age age 8wks
23120
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_Granu16 splenic granulocytes (percentage of total viable cells)
, at age age 16wks
23121
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
pct_Mono8 splenic monocytes (percentage of total viable cells)
, at age age 8wks
23122
|
Female |
4 |
10 |
10 |
10 |
5 |
30 |
10 |
10 |
5 |
5 |
15 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
20 |
15 |
10 |
10 |
10 |
|
pct_Mono16 splenic monocytes (percentage of total viable cells)
, at age age 16wks
23123
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
10 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|
bw8 body weight
, at age age 8wks
23130
|
Female |
4 |
5 |
10 |
5 |
5 |
25 |
10 |
10 |
5 |
5 |
10 |
Male |
5 |
5 |
10 |
10 |
5 |
15 |
14 |
15 |
5 |
5 |
10 |
|
bw16 body weight
, at age age 16wks
23131
|
Female |
|
5 |
10 |
|
10 |
5 |
9 |
|
10 |
5 |
5 |
Male |
|
|
9 |
|
5 |
|
10 |
|
5 |
5 |
10 |
|